James Investment Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$33.6M |
| 2 |
ANDV
Andeavor
ANDV
|
+$24.3M |
| 3 |
DuPont de Nemours
DD
|
+$21.7M |
| 4 |
Apple
AAPL
|
+$21.4M |
| 5 |
Ball Corp
BALL
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$33.7M |
| 2 |
Globe Life
GL
|
+$18.1M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$15.4M |
| 4 |
ConocoPhillips
COP
|
+$12.2M |
| 5 |
FINL
Finish Line
FINL
|
+$11.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.89% |
| 2 | Consumer Discretionary | 13.49% |
| 3 | Financials | 11.92% |
| 4 | Technology | 9.21% |
| 5 | Healthcare | 7.55% |
Similar funds
James Investment Research's Q4 2014 Portfolio in Review
As of Q4 2014, James Investment Research held 541 positions worth $3.67B, up 15% from $3.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
James Investment Research deployed $376M of net new capital in Q4 2014, opening 33 new positions and adding to 186 existing holdings. Its largest new stake was FedEx: 82,911 shares worth $14.4M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was CIMAREX ENERGY CO, an estimated $33.7M trimmed.
- James Investment Research's largest Q4 2014 buy was FedEx: 82,911 shares worth $14.4M.
- James Investment Research added most to Keurig Dr Pepper in Q4 2014, an estimated $33.6M increase.
- James Investment Research's biggest Q4 2014 reduction was CIMAREX ENERGY CO, cutting an estimated $33.7M.
- James Investment Research fully exited AK Steel Holding Corp in Q4 2014, selling an estimated $5.5M.
- James Investment Research's ten largest holdings make up 21% of its $3.67B portfolio in Q4 2014.
- James Investment Research opened 33 new positions and closed 34 in Q4 2014.
- James Investment Research's portfolio value rose 15% quarter-over-quarter to $3.67B.
Based on James Investment Research's 13F filing for Q4 2014, filed 9 Jan 2015.